Novartis
NVS
NVS
1,088 hedge funds and large institutions have $13.8B invested in Novartis in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 323 increasing their positions, 457 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $16.9B → $13.8B (-$3.02B)
29% less repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 457
34% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 95
Holders
1,088
Holding in Top 10
10
Calls
$441M
Puts
$204M
Top Buyers
| 1 | +$265M | |
| 2 | +$36.6M | |
| 3 | +$35.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$26.5M |
| 5 |
CI
Cambiar Investors
Denver,
Colorado
|
+$25.1M |
Top Sellers
| 1 | -$772M | |
| 2 | -$214M | |
| 3 | -$114M | |
| 4 |
Parnassus Investments
San Francisco,
California
|
-$105M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$68M |